In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Institut Biochimique SA

https://www.ibsagroup.com/

Latest From Institut Biochimique SA

Start-Up Quarterly Statistics, Q1 2016

Start-ups raised $1.8 billion in Q1 2016. Biopharma companies penned 33 alliances; 14 acquisitions were signed (11 in the biopharma industry).

BioPharmaceutical Medical Device

Medical Device Deals Update, March 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2016.

Medical Device

FDA Lull In Rx Promotion Citations Continues; Guidances May Be Bigger Priority

Even with recent letters, Office of Prescription Drug Promotion’s slow pace continues from 2014’s record low.

BioPharmaceutical Regulation

Social Media Monitoring: The Next Frontier In Corp. Integrity Agreements?

Expert questions whether companies could be required to monitor social media posts and search engine results as part of a future corporate integrity agreement.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
  • Other Names / Subsidiaries
    • AMSA Italy
    • Gelfipharma Italy
    • IBSA
    • IBSA Italy
    • IBSA Pharma Hungary
    • IBSA Slovakia
    • Laboratoires Genevrier France
    • Rizhao Lanshan China
UsernamePublicRestriction

Register